MiRagen Therapeutics Garners $20,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9d85271-704c-40c7-963f-afbf0641b017&Preview=1
Date
4/24/2012
Company Name
MiRagen Therapeutics
Mailing Address
6200 Lookout Rd Boulder, CO 80301
Company Description
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Website
http://www.miragentherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$20,000,000
Transaction Round
Series B
Proceeds Purposes
The funding enables miRagen to advance the development of its compelling microRNA-based therapeutics pipeline.
M&A Terms
Venture Investor
Remeditex Ventures
Venture Investor
Atlas Venture
Venture Investor
Boulder Ventures
Venture Investor
Amgen Ventures
Venture Investor
Broadview Ventures